High materiality7/10
Faeth Therapeutics initiated with a Buy at Needham
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Needham initiated Faeth Therapeutics with a Buy rating; target $56 vs current price $32.1; price change since signal -0.31%.
- Needham initiates Buy on FTH; target $56; current $32.10; price change -0.31%.
Key facts
- 01
Target: $56
- 02
Posted price: $32.1
- 03
Analyst firm: Needham
- 04
Analyst: Gil Blum
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.